|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
US7129390B2
(en)
*
|
1997-10-16 |
2006-10-31 |
Avigenics, Inc |
Poultry Derived Glycosylated Interferon Alpha 2b
|
|
ES2221717T3
(es)
|
1997-12-08 |
2005-01-01 |
Emd Lexigen Research Center Corp. |
Proteinas de fusion heterodimeras utiles para inmunoterapia dirigida e inmunoestimulacion general.
|
|
CA2330527A1
(en)
*
|
1998-06-15 |
1999-12-23 |
Genzyme Transgenics Corporation |
Erythropoietin analog-human serum albumin fusion
|
|
US20050181482A1
(en)
*
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
|
US20030005468A1
(en)
*
|
1998-06-19 |
2003-01-02 |
Meade Harry M. |
Methods and vectors for improving nucleic acid expression
|
|
GB9817084D0
(en)
*
|
1998-08-06 |
1998-10-07 |
Wood Christopher B |
A method for promoting extra-heptic production of proteins for the correction of hypoalbuminaemia,anaemia,thrombocytopenia and/or coagulation disorders
|
|
US7304150B1
(en)
*
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
US6617135B1
(en)
|
1999-08-09 |
2003-09-09 |
Emd Lexigen Research Center Corp. |
Multiple cytokine protein complexes
|
|
WO2001019842A1
(en)
*
|
1999-09-17 |
2001-03-22 |
Genzyme Transgenics Corporation |
Subunit optimized fusion proteins
|
|
CA2391080A1
(en)
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
|
DK1252192T3
(da)
|
2000-02-11 |
2006-11-20 |
Merck Patent Gmbh |
Forbedring af antistofbaserede fusionsproteiners serumhalveringstid
|
|
US6946134B1
(en)
|
2000-04-12 |
2005-09-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP2003530838A
(ja)
*
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
|
RU2272644C2
(ru)
|
2000-06-29 |
2006-03-27 |
Мерк Патент Гмбх |
Усиление иммунной реакции, медиатором которой является слитый протеин антитело-цитокин, при помощи комбинированного лечения агентами, увеличивающими поглощение иммуноцитокина
|
|
US20040226052A1
(en)
*
|
2000-10-13 |
2004-11-11 |
Meade Harry M. |
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
|
UA93662C2
(uk)
*
|
2000-12-07 |
2011-03-10 |
Эли Лилли Энд Компани |
Гетерологічний пептидильований глюкагон-подібний білок та його застосування для виготовлення лікарського засобу для лікування пацієнтів, що страждають на ожиріння або інсулінонезалежний цукровий діабет
|
|
WO2002064085A2
(en)
|
2001-02-02 |
2002-08-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
|
|
KR100900176B1
(ko)
|
2001-03-07 |
2009-06-02 |
메르크 파텐트 게엠베하 |
하이브리드 이소타입 항체 부분구조를 포함하는 단백질을위한 발현 기술
|
|
US6992174B2
(en)
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
|
US7507413B2
(en)
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CA2446087C
(en)
|
2001-05-03 |
2013-06-18 |
Stephen D. Gillies |
Recombinant tumor specific antibody and use thereof
|
|
WO2003030821A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
CA2468499A1
(en)
|
2001-11-28 |
2003-06-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
Erythropoietin dosing regimen for treating anemia
|
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
|
BR0214650A
(pt)
|
2001-12-04 |
2005-05-03 |
Merck Patent Gmbh |
Imunocitoquinas com seletividade modulada
|
|
ES2425738T3
(es)
*
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
AU2002364587A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
AU2003218045A1
(en)
|
2002-03-11 |
2003-09-29 |
Ortho Mcneil Pharmaceutical, Inc |
Methods for shp1 mediated neuroprotection
|
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
|
JP4494977B2
(ja)
|
2002-12-17 |
2010-06-30 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｇｄ２に結合するマウス１４．１８抗体のヒト化抗体（ｈ１４．１８）およびそのｉｌ−２融合タンパク質
|
|
EP1594530A4
(de)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
Albuminfusionsproteine
|
|
US7803362B2
(en)
*
|
2003-01-24 |
2010-09-28 |
Synageva Biopharma Corp. |
Glycosylated interferon alpha
|
|
US20040198663A1
(en)
*
|
2003-04-04 |
2004-10-07 |
Baker John E. |
Method of treating cardiac ischemia by using erythropoietin
|
|
WO2004101620A2
(en)
*
|
2003-05-01 |
2004-11-25 |
Compound Therapeutics, Inc. |
Serum albumin scaffold-based proteins and uses thereof
|
|
WO2005063808A1
(en)
|
2003-12-31 |
2005-07-14 |
Merck Patent Gmbh |
Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS
|
|
EP1729795B1
(de)
|
2004-02-09 |
2016-02-03 |
Human Genome Sciences, Inc. |
Albuminfusionsproteine
|
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
|
JP2008512385A
(ja)
*
|
2004-09-03 |
2008-04-24 |
アルザ コーポレイション |
アルブミンの内因的に形成された結合体
|
|
CA2634495A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Conjuchem Biotechnologies Inc. |
Process for the production of preformed conjugates of albumin and a therapeutic agent
|
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
|
EP1816201A1
(de)
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
|
|
US7812127B2
(en)
|
2006-03-17 |
2010-10-12 |
Synageva Biopharma Corp. |
Glycosylated human G-CSF
|
|
DK2007885T3
(da)
*
|
2006-04-11 |
2010-11-08 |
Csl Behring Gmbh |
Fremgangsmåde til forøgelse af in vivo-genvindingen af terapeutiske polypeptider
|
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
|
BRPI0712383A2
(pt)
|
2006-06-07 |
2012-07-10 |
Human Genome Sciences Inc |
proteìnas de fusão da albumina
|
|
US7939632B2
(en)
*
|
2006-06-14 |
2011-05-10 |
Csl Behring Gmbh |
Proteolytically cleavable fusion proteins with high molar specific activity
|
|
DK2615108T3
(en)
|
2006-09-08 |
2017-01-30 |
Ambrx Inc |
Modified human plasma polypeptide or fc scaffolds and their applications
|
|
WO2008057161A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Synageva Biopharma Corp |
Avian derived erythropoietin
|
|
US20090105462A1
(en)
*
|
2006-11-09 |
2009-04-23 |
Ivarie Robert D |
Glycosylated erythropoietin
|
|
WO2008056961A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Boryung Pharmaceutical Co., Ltd |
A novel fusion protein, cell lines expressing the same and preparation method thereof
|
|
KR101248252B1
(ko)
|
2006-11-28 |
2013-03-27 |
한올바이오파마주식회사 |
변형된 에리스로포이에틴 폴리펩티드와 이의 치료용 용도
|
|
US8754194B2
(en)
*
|
2006-12-22 |
2014-06-17 |
Csl Behring Gmbh |
Modified coagulation factors with prolonged in vivo half-life
|
|
MX2009008104A
(es)
|
2007-02-02 |
2009-08-07 |
Amgen Inc |
Hepcidina, antagonistas de hepcidina y metodos de uso.
|
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
|
EP2176414A4
(de)
*
|
2007-08-08 |
2011-01-26 |
Cho A Pharm Co Ltd |
Expressionsvektor für brustdrüsenspezifisches menschliches erythropoietin, transgenes tier und verfahren zur herstellung von menschlichem erythropoietin unter verwendung davon
|
|
WO2009043049A2
(en)
*
|
2007-09-27 |
2009-04-02 |
Amgen Inc. |
Pharmaceutical formulations
|
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
|
US8431770B2
(en)
|
2008-01-07 |
2013-04-30 |
Synageva Biopharma Corp. |
Method of producing sialytransferase-modified proteins
|
|
CA2711826C
(en)
|
2008-01-25 |
2018-02-27 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
|
US9938333B2
(en)
|
2008-02-08 |
2018-04-10 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
|
US9315577B2
(en)
|
2008-05-01 |
2016-04-19 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
|
AU2008359017B2
(en)
*
|
2008-06-30 |
2013-01-17 |
Cho-A Pharm Co., Ltd. |
A gene of porcine beta-casein, a promoter of the same and the use thereof
|
|
US9738694B2
(en)
*
|
2008-06-30 |
2017-08-22 |
Cho-A Pharm. Co., Ltd. |
Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
|
|
US8278418B2
(en)
|
2008-09-26 |
2012-10-02 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
|
US8318167B2
(en)
|
2008-11-13 |
2012-11-27 |
The General Hospital Corporation |
Methods and compositions for regulating iron homeostasis by modulation of BMP-6
|
|
US8815242B2
(en)
*
|
2009-05-27 |
2014-08-26 |
Synageva Biopharma Corp. |
Avian derived antibodies
|
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
|
US9051358B2
(en)
|
2009-11-19 |
2015-06-09 |
Zhejiang University |
Nonnatural collagen-like protein and use thereof
|
|
HUE026173T2
(en)
|
2010-06-07 |
2016-05-30 |
Amgen Inc |
pharmaceutical Pump
|
|
WO2012015692A2
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
|
WO2012090067A1
(en)
|
2010-12-30 |
2012-07-05 |
Lfb Biotechnologies |
Glycols as pathogen inactivating agents
|
|
AU2012236573B2
(en)
|
2011-03-31 |
2016-06-02 |
Amgen Inc. |
Vial adapter and system
|
|
TR201905991T4
(tr)
|
2011-04-20 |
2019-05-21 |
Amgen Inc |
Oto enjektör aparatı.
|
|
AR087433A1
(es)
*
|
2011-08-08 |
2014-03-26 |
Merck Sharp & Dohme |
Analogos de insulina n-glicosilados
|
|
EP3045188B1
(de)
|
2011-10-14 |
2020-12-23 |
Amgen Inc. |
Injektor und verfahren zur montage
|
|
EP2922590B1
(de)
|
2012-11-21 |
2020-02-05 |
Amgen Inc. |
Arzneimittelabgabevorrichtung
|
|
CN105308068A
(zh)
|
2013-02-13 |
2016-02-03 |
法国化学与生物科技实验室 |
高度半乳糖基化的抗TNF-α抗体及其用途
|
|
BR112015019348A2
(pt)
|
2013-02-13 |
2017-08-22 |
Lab Francais Du Fractionnement |
Métodos para produção de proteína com glicosilação modificada e com sialilação aumentada, para aumentar a atividade de sialil transferase na glândula mamária e para produzir sialil transferase, proteína com glicosilação modificada ou proteína com sialilação aumentada, composição, sialil transferase, mamífero transgênico, e, célula epitelial mamária
|
|
SMT202000088T1
(it)
|
2013-02-18 |
2020-03-13 |
Vegenics Pty Ltd |
Molecole leganti ligandi e relativi usi
|
|
KR102218494B1
(ko)
|
2013-03-15 |
2021-02-19 |
인트린식 라이프사이언시스, 엘엘씨 |
항-헵시딘 항체 및 그의 용도
|
|
TWI614041B
(zh)
|
2013-03-15 |
2018-02-11 |
安美基公司 |
用於注射器之匣盒
|
|
SG11201507417RA
(en)
|
2013-03-15 |
2015-10-29 |
Amgen Inc |
Body contour adaptable autoinjector device
|
|
US10092703B2
(en)
|
2013-03-15 |
2018-10-09 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
EP2976117B1
(de)
|
2013-03-22 |
2020-12-30 |
Amgen Inc. |
Injektor und verfahren zur montage
|
|
KR20160029840A
(ko)
|
2013-07-05 |
2016-03-15 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
친화성 크로마토그래피 매트릭스
|
|
CA2920894C
(en)
|
2013-10-24 |
2023-03-14 |
Amgen Inc. |
Injector and method of assembly
|
|
EP3957345B1
(de)
|
2013-10-24 |
2025-12-10 |
Amgen Inc. |
Arzneimittelabgabesystem mit temperaturempfindlicher steuerung
|
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
MX388536B
(es)
|
2014-05-07 |
2025-03-20 |
Amgen Inc |
Autoinyector con elementos reductores del shock.
|
|
CN106470717B
(zh)
|
2014-06-03 |
2020-09-11 |
安姆根有限公司 |
药物递送系统和使用方法
|
|
AU2015321462B2
(en)
|
2014-09-22 |
2020-04-30 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
|
AU2015332557B2
(en)
|
2014-10-14 |
2020-05-14 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
ES2785311T3
(es)
|
2014-12-19 |
2020-10-06 |
Amgen Inc |
Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
|
|
EP3848072A1
(de)
|
2014-12-19 |
2021-07-14 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit näherungssensor
|
|
CA3069716C
(en)
|
2015-02-17 |
2021-11-09 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3261690B1
(de)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit nadelschutzmechanismus mit abstimmbarem widerstandsschwellwert gegenüber der bewegung des nadelschutzes
|
|
FR3038517B1
(fr)
|
2015-07-06 |
2020-02-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation de fragments fc modifies en immunotherapie
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
JP6959229B2
(ja)
*
|
2015-10-23 |
2021-11-02 |
アポジェニックス アーゲー |
一本鎖ｇｉｔｒ受容体アゴニストタンパク質
|
|
WO2017100501A1
(en)
|
2015-12-09 |
2017-06-15 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
WO2017160799A1
(en)
|
2016-03-15 |
2017-09-21 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
|
EP3458988B1
(de)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Datenverschlüsselung in medizinischen vorrichtungen mit eingeschränkter rechenfähigkeit
|
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
JP2020503976A
(ja)
|
2017-01-17 |
2020-02-06 |
アムジエン・インコーポレーテツド |
注入デバイスならびに関連する使用および組立方法
|
|
EP3582829A1
(de)
|
2017-02-17 |
2019-12-25 |
Amgen Inc. |
Einführmechanismus für eine arzneimittelabgabevorrichtung
|
|
MX2019009625A
(es)
|
2017-02-17 |
2019-10-09 |
Amgen Inc |
Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje.
|
|
EP3592403B1
(de)
|
2017-03-06 |
2025-08-20 |
Amgen Inc. |
Wirkstofffreisetzungsvorrichtung mit aktivierungsverhinderungsfunktion
|
|
CA3052482A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
|
AU2018230486B2
(en)
|
2017-03-09 |
2023-05-11 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
EP3570871B1
(de)
|
2017-03-20 |
2020-11-18 |
H. Hoffnabb-La Roche Ag |
Verfahren für in-vitro-glyco-engineering eines erythropoiesestimulierenden proteins
|
|
CN118743804A
(zh)
|
2017-03-28 |
2024-10-08 |
美国安进公司 |
柱塞杆和注射器组件系统以及方法
|
|
CA3066399A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
AU2018288604B2
(en)
|
2017-06-22 |
2023-12-21 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
MA49461A
(fr)
|
2017-06-23 |
2020-04-29 |
Amgen Inc |
Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur
|
|
MA49562A
(fr)
|
2017-07-14 |
2020-05-20 |
Amgen Inc |
Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
|
|
US11672733B2
(en)
|
2017-07-21 |
2023-06-13 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
JP2020528296A
(ja)
|
2017-07-25 |
2020-09-24 |
アムジエン・インコーポレーテツド |
ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
|
|
WO2019032482A2
(en)
|
2017-08-09 |
2019-02-14 |
Amgen Inc. |
HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM
|
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
ES2939292T3
(es)
|
2017-10-04 |
2023-04-20 |
Amgen Inc |
Adaptador de flujo para dispositivo de administración de fármacos
|
|
EP4257164A3
(de)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit verriegelungsvorrichtung und zugehöriges montageverfahren
|
|
EP3694578B1
(de)
|
2017-10-09 |
2025-09-24 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit antriebsanordnung sowie zugehöriges verfahren zur montage
|
|
MA50528A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Systèmes et approches pour stériliser un dispositif d'administration de médicament
|
|
WO2019089178A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
US12053618B2
(en)
|
2017-11-06 |
2024-08-06 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
IL319987A
(en)
|
2017-11-10 |
2025-06-01 |
Amgen Inc |
Plungers for drug delivery devices
|
|
JP7747438B2
(ja)
|
2017-11-16 |
2025-10-01 |
アムジエン・インコーポレーテツド |
失速及び終点検出を有するオートインジェクタ
|
|
SG11202003004RA
(en)
|
2017-11-16 |
2020-04-29 |
Amgen Inc |
Door latch mechanism for drug delivery device
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
US12115360B2
(en)
|
2018-07-24 |
2024-10-15 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
MX2021000749A
(es)
|
2018-07-24 |
2021-03-29 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
US12042645B2
(en)
|
2018-07-24 |
2024-07-23 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
EP3829692A1
(de)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Flüssigkeitsweganordnungen für wirkstofffreisetzungsvorrichtung
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
EP3856283A1
(de)
|
2018-09-28 |
2021-08-04 |
Amgen Inc. |
Anordnung zur aktivierung des muskeldrahtvorschubs für eine medikamentenabgabevorrichtung
|
|
AU2019352616B2
(en)
|
2018-10-02 |
2024-10-10 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
US12151089B2
(en)
|
2018-10-05 |
2024-11-26 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
SG11202103800RA
(en)
|
2018-10-15 |
2021-05-28 |
Amgen Inc |
Drug delivery device having damping mechanism
|
|
JP2022504805A
(ja)
|
2018-10-15 |
2022-01-13 |
アムジエン・インコーポレーテツド |
薬物送達デバイスのプラットフォーム式組み立てプロセス
|
|
AU2019370159B2
(en)
|
2018-11-01 |
2025-05-29 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
US11213620B2
(en)
|
2018-11-01 |
2022-01-04 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
JP7510952B2
(ja)
|
2019-04-24 |
2024-07-04 |
アムジエン・インコーポレーテツド |
シリンジ滅菌確認アセンブリ及び方法
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
CA3174377A1
(en)
*
|
2020-04-09 |
2021-10-14 |
Samuel Newton Sathyanesan |
Compositions comprising recombinant epo and methods of use thereof
|
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
|
CA3191387A1
(en)
|
2020-09-30 |
2022-04-07 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
|
WO2022115396A1
(en)
*
|
2020-11-25 |
2022-06-02 |
Jecho Laboratories, Inc. |
Il-7 fusion protein and related methods
|
|
CA3217207A1
(en)
|
2021-05-21 |
2022-11-24 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
EP4612312A1
(de)
|
2022-11-02 |
2025-09-10 |
F. Hoffmann-La Roche AG |
Verfahren zur herstellung von glycoproteinzusammensetzungen
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|